AngioDynamics to Hold Fiscal 2006 Second Quarter Financial Results Conference Call on Monday, December 19, 2005
Eamonn P. Hobbs, president and chief executive officer, and Joseph G. Gerardi, chief financial officer, will host an investment community conference call beginning at 4:30 p.m. Eastern Time on December 19 to discuss these results and to answer questions.
To participate in the live call by telephone, please dial 866-578-5747 from the U.S., or for international callers, please dial 617-213-8054. Please enter the passcode 53147624.
Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics' web site at http://investor.angiodynamics.com/. To listen to the live call, please go to the web site 15 minutes prior to its start to register, download, and install the necessary audio software.
A replay will be available on the web site. A telephone replay will be available from 6:30 p.m. Eastern Time on December 19, 2005 through 11:59 p.m. Eastern Time on December 26, 2005 by dialing 888-286-8010 (domestic) or 617-801-6888 (international) and entering conference ID number 30654415.
The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (www.streetevents.com), a password-protected event management site.
About AngioDynamics
AngioDynamics, Inc. (www.angiodynamics.com) is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics, Inc. designs, develops, manufactures and markets a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. The Company's diverse product line includes angiographic catheters, hemodialysis catheters, endovascular laser venous system products, PTA dilation balloon catheters, image-guided vascular access products, thrombolytic products and drainage products.
CONTACT: AngioDynamics, Inc.
Joe Gerardi, 800-772-6446 x115
www.AngioDynamics.com
or
Investor Relations Contacts:
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com
SOURCE: AngioDynamics, Inc.